.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Accenture
Mallinckrodt
Harvard Business School
Queensland Health
Novartis
AstraZeneca
QuintilesIMS
Teva
Moodys

Generated: July 28, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203778

« Back to Dashboard
NDA 203778 describes FLUDEOXYGLUCOSE F18, which is a drug marketed by Trustees Univ Pa, Ucsf Rodiopharm, Cardinal Health 414, Methodist Hosp Res, Downstate Clincl, Wi Medcl Cyclotron, Biomedcl Res Fdn, Spectron Mrc Llc, Ucla Biomedical, Mcprf, Ncm Usa Bronx Llc, Brigham Womens, Triad Isotopes Inc, Cpdc, Univ Michigan, Ma General Hosp, Wusm Cyclotron, Midwest Medcl, Hot Shots Nm Llc, Kreitchman Pet Ctr, Essential Isotopes, Precision Nuclear, Univ Tx Md Anderson, Kettering Medctr, Global Isotopes Llc, Lantheus Medical, Shertech Labs Llc, Houston Cyclotron, Weill Medcl Coll, Feinstein, Queen Hamamatsu Pet, Mips Crf, 3d Imaging Drug, Mem Sloan-kettering, Childrens Hosp Mi, Petnet, Uihc Pet Imaging, Zevacor Pharma Inc, Univ North Dakota, and Univ Utah Cyclotron, and is included in forty-one NDAs. It is available from thirty-four suppliers. Additional details are available on the FLUDEOXYGLUCOSE F18 profile page.

The generic ingredient in FLUDEOXYGLUCOSE F18 is fludeoxyglucose f-18. There are eight drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the fludeoxyglucose f-18 profile page.

Summary for NDA: 203778

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAVENOUSStrength20-300mCi/ML
Approval Date:Oct 30, 2015TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Mallinckrodt
Healthtrust
Deloitte
Merck
QuintilesIMS
Chubb
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot